MedTrace Logo

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

NCT01178437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2011-03-08

No results posted yet for this study

Summary

The aim of the study is to prove the feasibility and safety of transcutaneous, electrical stimulation of the vagus nerve in patients with difficult-to-treat forms of epilepsy.

Conditions

Interventions

DEVICE

T-VNS® Stimulator cM02 (Transcutaneous Stimulation of the Vagus Nerve)

daily, transcutaneous, electrical stimulation of the vagus nerve by the t-VNS device for a period of 9 months

Sponsors & Collaborators

  • cerbomed GmbH

    lead INDUSTRY

Principal Investigators

  • Stefan Herrmann, MD · University of Erlangen-Nürnberg

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-09-30
Completion
2011-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01178437 on ClinicalTrials.gov